<div id="readability-page-1"><p>Palomar Holdings, Inc. (NASDAQ:PLMR - Get Free Report) has earned an average rating of &#34;Moderate Buy&#34; from the eight research firms that are  covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to  the company. The average 12 month target price among analysts that have covered the stock in the last year is $157.6667.</p><ul><li>Down Over 80%, is Pet Insurer Trupanion Worth the Risk Premium?</li></ul><p>Several analysts have weighed in on the stock. Weiss Ratings  reissued a &#34;hold (c+)&#34; rating on shares of Palomar in a research note on Wednesday, October 8th. Evercore ISI decreased their price objective on Palomar from $168.00 to $134.00 and set an &#34;in-line&#34; rating on the stock in a report on Wednesday, October 1st. Keefe, Bruyette &amp; Woods increased their target price on Palomar from $164.00 to $170.00 and gave the company an &#34;outperform&#34; rating in a report on Tuesday, November 11th. JPMorgan Chase &amp; Co. raised their price target on Palomar from $137.00 to $145.00 and gave the stock an &#34;overweight&#34; rating in a research report on Monday, November 10th. Finally, Wall Street Zen cut Palomar from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, December 20th.</p><p><b>Read Our Latest Stock Report on PLMR</b></p><h2>Palomar Price Performance</h2><ul><li>3 Small Cap Stocks That May Someday be Large Caps</li></ul><p>Shares of NASDAQ PLMR opened at $136.29 on Thursday. The stock has a market capitalization of $3.61 billion, a P/E ratio of 21.26 and a beta of 0.50. Palomar has a one year low of $98.42 and a one year high of $175.85. The firm's 50 day simple moving average is $122.35 and its two-hundred day simple moving average is $127.96. </p><p>Palomar (NASDAQ:PLMR - Get Free Report) last announced its quarterly earnings data on Friday, December 16th. The company reported $0.07 earnings per share (EPS) for the quarter. Palomar had a net margin of 22.59% and a return on equity of 21.93%. The company had revenue of $65.74 million during the quarter.  As a group, equities analysts expect that  Palomar will post 5.99 earnings per share for the current fiscal year. </p><h2>Insider Activity</h2><p>In other Palomar news, CFO T Christopher Uchida sold 782 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $128.84, for a total transaction of $100,752.88. Following the completion of the sale, the chief financial officer owned 7,916 shares of the company's stock, valued at $1,019,897.44. This represents a 8.99% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Mac Armstrong sold 5,000 shares of the firm's stock in a transaction on Friday, November 21st. The stock was sold at an average price of $122.86, for a total transaction of $614,300.00. Following the completion of the sale, the chief executive officer directly owned 358,388 shares in the company, valued at approximately $44,031,549.68. This trade represents a 1.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 14,803 shares of company stock valued at $1,768,671. 3.70% of the stock is owned by corporate insiders. </p><h2>Institutional Trading of Palomar</h2><p>Several large investors have recently modified their holdings of PLMR. Dynamic Technology Lab Private Ltd bought a new position in shares of  Palomar during the first quarter valued at approximately $314,000.  Advisors Asset Management Inc. boosted its holdings in  Palomar by 867.0% in the first quarter. Advisors Asset Management Inc. now owns 8,229 shares of the company's stock valued at $1,128,000 after acquiring an additional 7,378 shares in the last quarter.  Trexquant Investment LP purchased a new position in  Palomar during the 1st quarter valued at $591,000.  Coppell Advisory Solutions LLC raised its holdings in  Palomar by 3,912.3% in the 1st quarter. Coppell Advisory Solutions LLC now owns 8,787 shares of the company's stock worth $1,205,000 after purchasing an additional 8,568 shares in the last quarter.  Finally, Alliancebernstein L.P. raised its holdings in  Palomar by 322.4% in the 1st quarter. Alliancebernstein L.P. now owns 127,383 shares of the company's stock worth $17,462,000 after purchasing an additional 97,226 shares in the last quarter. 90.25% of the stock is owned by institutional investors. </p><h2>About Palomar</h2> (Get Free Report)<p>Palomar Holdings, Inc <span>NASDAQ: PLMR<span></span></span> is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.  </p><p>In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Palomar</li><li>Do not delete, read immediately</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>Can Any Expenses Be Deducted From Capital Gains Tax?</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li><li>Forget AI, This Will Be the Next Big Tech Breakthrough</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExNUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExNUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Palomar Right Now?</h2><p>Before you consider Palomar, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Palomar wasn't on the list.</p><p>While Palomar currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

PLMR

<p>Palomar Holdings, Inc. (NASDAQ:PLMR) has received an average "Moderate Buy" rating from eight research firms. Analysts have set an average 12-month target price of $157.67. Recent analyst actions include price target adjustments by Evercore ISI, Keefe, Bruyette & Woods, and JPMorgan Chase & Co. Insider trading activity includes sales by CFO T Christopher Uchida and CEO Mac Armstrong. Institutional investors have significantly modified their holdings in the company. Palomar is a specialty insurance holding company focused on medical stop-loss coverage.</p>

Palomar Holdings, Inc. (NASDAQ:PLMR) Given Average Rating of "Moderate Buy" by Analysts